Skip to content
OpenCapital
Get started

Perspective Therapeutics CATX EPS (Basic)

EPS (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
$8.27+169%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$0.10-137%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
-$0.46-21.1%
Immunome logo
ImmunomeIMNM
-$0.48+7.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$1.15-5.5%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$1.83+72.6%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%—

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0×0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's EPS (basic)?
Perspective Therapeutics (CATX) reported EPS (basic) of -$0.25 in Q1 2026.
How has Perspective Therapeutics's EPS (basic) changed year-over-year?
Perspective Therapeutics's EPS (basic) decreased by 0.0% year-over-year, from -$0.25 to -$0.25.
What is the long-term trend for Perspective Therapeutics's EPS (basic)?
Over 4 years (2021 to 2025), Perspective Therapeutics's EPS (basic) has grown at a 130.0% compound annual growth rate (CAGR), from -$0.05 to -$1.40.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.